EBOS Group Limited (ASX:EBO)

Market Cap	3.77B -45.6%
Revenue (ttm)	13.04B +3.5%
Net Income	229.47M -6.7%
EPS	1.13 -11.1%
Shares Out	n/a
PE Ratio	16.44
Forward PE	14.06
Dividend	1.08 (5.85%)
Ex-Dividend Date	Mar 5, 2026

Volume	107,720
Average Volume	133,216
Open	18.10
Previous Close	18.36
Day's Range	18.10 - 18.56
52-Week Range	18.10 - 38.23
Beta	0.18
RSI	30.27
Earnings Date	Feb 25, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 5,800
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EBO

Financial Performance

In fiscal year 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.